Details of the Drug

General Information of Drug (ID: DMLCP8I)

Drug Name

BNT163

Indication

Disease Entry	ICD 11	Status	REF
Herpes simplex infection	1F00	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05432583) Phase I, Randomized, Observer-blinded, Placebo-controlled, 2-part, Dose Escalation and Expanded Safety Evaluation Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Prophylactic Vaccine for the Prevention of Genital Lesions Caused by Herpes Simplex Virus (HSV)-2 and Potentially HSV-1. U.S.National Institutes of Health.